Gene expression | ||||
Radioligand | Gene | Human exocrine pancreas | Human pancreatic islets | Human primary β-cells* |
11C-(+)-PHNO, 11C-FLB457, 11C-raclopride | DRD2 | 63 | 55 | 74* |
DRD3* | 1* | 4* | 69* | |
11C-DASB | SLC6A4 | 59 | 69 | 54* |
11C-AS2471907 | HSD11B1 | 44 | 75 | 48* |
11C-UCB-J | SV2A | 16 | 72 | 86* |
↵* Retrospective analysis for relative gene expression was examined after completion of PET scans to provide insight into differences of pancreas uptake among the 3 D2/D3 receptor radioligands (11C-raclopride, 11C-FLB457, and 11C-(+)-PHNO). DRD2 = dopamine receptor 2; DRD3 = –dopamine receptor 3; SLC6A4 = serotonin transporter; HSD11B1 = 11β-hydroxysteroid dehydrogenase type 1 enzyme inhibitor; SV2A = synaptic vesicle protein 2A.
Expression group rankings: none (0–25), low (25–50), moderate (50–75), enriched (75–100).